Zenith Drugs Limited (NSE:ZENITHDRUG)
India · Delayed Price · Currency is INR 69.85
+0.95 (1.38%)
At close: Sep 11, 2025
Zenith Drugs Revenue
In the fiscal year ending March 31, 2025, Zenith Drugs had annual revenue of 1.33B INR with 1.29% growth. Zenith Drugs had revenue of 311.05M in the quarter ending March 31, 2024.
Revenue
1.33B
Revenue Growth
+1.29%
P/S Ratio
0.88
Revenue / Employee
n/a
Employees
126
Market Cap
1.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.33B | 17.00M | 1.29% |
| Mar 31, 2024 | 1.32B | 171.01M | 14.93% |
| Mar 31, 2023 | 1.15B | 228.64M | 24.95% |
| Mar 31, 2022 | 916.55M | 182.53M | 24.87% |
| Mar 31, 2021 | 734.02M | -48.67M | -6.22% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,839.41B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,503.84B |
| Infosys | 1,672.76B |
| Hindustan Unilever | 639.28B |